AAAAAA

   
Results: 1-14 |
Results: 14
ADJUVANT CHEMOTHERAPY IN WOMEN WITH HIGH-RISK BREAST-CANCER - AN INTENSIVE AND SHORT TREATMENT BONADONNA MODIFIED REGIMEN
Authors: VALDIVIA S GOMEZ H KAHATT C LEON L VIGIL C SANTILLANA S CASANOVA L CARRACEDO C FLORES C VALLEJOS C
Citation: S. Valdivia et al., ADJUVANT CHEMOTHERAPY IN WOMEN WITH HIGH-RISK BREAST-CANCER - AN INTENSIVE AND SHORT TREATMENT BONADONNA MODIFIED REGIMEN, Annals of oncology, 9, 1998, pp. 36-36
VP-16 (V)-IFOSFAMIDE (I)-CISPLATIN (P) IN FIRST-LINE THERAPY FOR POOR-RISK GERM-CELL TUMORS (PR-GCT)
Authors: RODRIGUEZ PW GOMEZ H CASANOVA L VALDIVIA S SANTILLANA S CARRACEDO C VAILLEJOS C
Citation: Pw. Rodriguez et al., VP-16 (V)-IFOSFAMIDE (I)-CISPLATIN (P) IN FIRST-LINE THERAPY FOR POOR-RISK GERM-CELL TUMORS (PR-GCT), Annals of oncology, 9, 1998, pp. 297-297
ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA TREATED WITH CHOP CHEMOTHERAPY PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR- IDENTIFICATION OF 2 AGE SUBGROUPS WITH DIFFERING HEMATOLOGIC TOXICITY
Authors: GOMEZ H MAS L CASANOVA L PEN DLK SANTILLANA S VALDIVIA S OTERO J RODRIGUEZ W CARRACEDO C VALLEJOS C
Citation: H. Gomez et al., ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA TREATED WITH CHOP CHEMOTHERAPY PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR- IDENTIFICATION OF 2 AGE SUBGROUPS WITH DIFFERING HEMATOLOGIC TOXICITY, Journal of clinical oncology, 16(7), 1998, pp. 2352-2358
RISK-FACTORS FOR TREATMENT-RELATED DEATH IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - RESULTS OF A MULTIVARIATE-ANALYSIS
Authors: GOMEZ H HIDALGO M CASANOVA L COLOMER R PEN DLK OTERO J RODRIGUEZ W CARRACEDO C CORTESFUNES H VALLEJOS C
Citation: H. Gomez et al., RISK-FACTORS FOR TREATMENT-RELATED DEATH IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - RESULTS OF A MULTIVARIATE-ANALYSIS, Journal of clinical oncology, 16(6), 1998, pp. 2065-2069
IFOSFAMIDE PLUS CISPLATIN AS PRIMARY CHEMOTHERAPY OF ADVANCED OVARIAN-CANCER
Authors: VALLEJOS C SOLIDORO A GOMEZ H CASTELLANO C BARRIGA O GALDOS R CASANOVA L OTERO J RODRIGUEZ W
Citation: C. Vallejos et al., IFOSFAMIDE PLUS CISPLATIN AS PRIMARY CHEMOTHERAPY OF ADVANCED OVARIAN-CANCER, Gynecologic oncology, 67(2), 1997, pp. 168-171
HCV AND LIVER-TRANSPLANTATION - PRELIMINARY-RESULTS OF A EUROPEAN MULTICENTRIC STUDY
Authors: FERAY C CACCAMO L GUGENHEIM J GONZALEZ M CASANOVA L BURRA P ALEXANDER G SHALM S SAMUEL D BISMUTH H
Citation: C. Feray et al., HCV AND LIVER-TRANSPLANTATION - PRELIMINARY-RESULTS OF A EUROPEAN MULTICENTRIC STUDY, Hepatology, 24(4), 1996, pp. 1533-1533
DOSE INTENSITY (DI) CHEMOTHERAPY IMPROVES DISEASE-FREE SURVIVAL IN ELDERLY AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PATIENTS TREATED WITH CONVENTIONAL CHOP
Authors: GOMEZ H SANTILLANA S CASANOVA L VALDIVIA S OTERO J MAS L VALLEJOS C
Citation: H. Gomez et al., DOSE INTENSITY (DI) CHEMOTHERAPY IMPROVES DISEASE-FREE SURVIVAL IN ELDERLY AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PATIENTS TREATED WITH CONVENTIONAL CHOP, European journal of cancer, 31A, 1995, pp. 802-802
TISSUE-SPECIFIC AND EFFICIENT EXPRESSION OF THE HUMAN SIMPLE EPITHELIAL KERATIN-8 GENE IN TRANSGENIC MICE
Authors: CASANOVA L BRAVO A WERE F RAMIREZ A JORCANO JJ VIDAL M
Citation: L. Casanova et al., TISSUE-SPECIFIC AND EFFICIENT EXPRESSION OF THE HUMAN SIMPLE EPITHELIAL KERATIN-8 GENE IN TRANSGENIC MICE, Journal of Cell Science, 108, 1995, pp. 811-820
AGE-RELATED TOXICITY PATTERN OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GMCSF) IN AGGRESSIVE MALIGNANT-LYMPHOMA PATIENTS (PTS) TREATED WITH CHEMOTHERAPY (CT)
Authors: SANTILLANA S GOMEZ H CASANOVA L KAHATT C VALDIVIA S OTERO J RODRIGUEZ W CARRACEDO C VALLEJOS C
Citation: S. Santillana et al., AGE-RELATED TOXICITY PATTERN OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GMCSF) IN AGGRESSIVE MALIGNANT-LYMPHOMA PATIENTS (PTS) TREATED WITH CHEMOTHERAPY (CT), Blood, 86(10), 1995, pp. 2799-2799
DIFFERENCES IN EFFICACY AND TOLERANCE IN ELDERLY PATIENTS WITH INTERMEDIATE GRADE LYMPHOMA (NHL) TREATED WITH FULL-DOSE CHOP AND GM-CSF
Authors: GOMEZ H SANTILLANA S CASANOVA L MAS L VALDIVIA S OTERO J RODRIGUEZ W CARRACEDO C VALLEJOS C
Citation: H. Gomez et al., DIFFERENCES IN EFFICACY AND TOLERANCE IN ELDERLY PATIENTS WITH INTERMEDIATE GRADE LYMPHOMA (NHL) TREATED WITH FULL-DOSE CHOP AND GM-CSF, Blood, 86(10), 1995, pp. 3239-3239
ADULT T-CELL LEUKEMIA - LYMPHOMA (ATL) IN PERU
Authors: RODRIGUEZ W MISAD O GARCIA J CASTRO O VALLEJOS C CASANOVA L OTERO J VALDIVIA S GOMEZ H SANTILLANA S FERREYROS G SILVA M SOLIDORO A
Citation: W. Rodriguez et al., ADULT T-CELL LEUKEMIA - LYMPHOMA (ATL) IN PERU, Blood, 86(10), 1995, pp. 3720-3720
IMPACT OF GMCSF (MOLGRAMOSTIN) IN THE DELIVERY OF FULL DOSE CHOP FOR ELDERLY PATIENTS WITH INTERMEDIATE GRADE LYMPHOMA
Authors: GOMEZ H MAS L CASANOVA L SANTILLANA S VALDIVIA S OTERO J RODRIGUEZ W CARRACEDO C VALLEJOS C
Citation: H. Gomez et al., IMPACT OF GMCSF (MOLGRAMOSTIN) IN THE DELIVERY OF FULL DOSE CHOP FOR ELDERLY PATIENTS WITH INTERMEDIATE GRADE LYMPHOMA, Blood, 84(10), 1994, pp. 10000582-10000582
BIWEEKLY INTENSIFIED CHOP (I-CHOP) REGIMEN USING RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GMCSF) IN NON-HODGKINS-LYMPHOMA - PRELIMINARY-REPORT
Authors: SANTILLANA S CASANOVA L ALDECOA F GOMEZ H SALAS F VALDIVIA S CARRACADO C RODRIGUEZ W OTERO J MAS L NUNEZ J VALLEJOS C
Citation: S. Santillana et al., BIWEEKLY INTENSIFIED CHOP (I-CHOP) REGIMEN USING RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GMCSF) IN NON-HODGKINS-LYMPHOMA - PRELIMINARY-REPORT, Blood, 84(10), 1994, pp. 10000586-10000586
INBREEDING IN SWISS BRAUNVIEH AND ITS INFLUENCE ON BREEDING VALUES PREDICTED FROM A REPEATABILITY ANIMAL-MODEL
Authors: CASANOVA L HAGGER C KUENZI N SCHNEEBERGER M
Citation: L. Casanova et al., INBREEDING IN SWISS BRAUNVIEH AND ITS INFLUENCE ON BREEDING VALUES PREDICTED FROM A REPEATABILITY ANIMAL-MODEL, Journal of dairy science, 75(4), 1992, pp. 1119-1126
Risultati: 1-14 |